| Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling P Marcato, CA Dean, RZ Liu, KM Coyle, M Bydoun, M Wallace, ... Molecular oncology 9 (1), 17-31, 2015 | 144 | 2015 |
| GLA-SE, a synthetic toll-like receptor 4 agonist, enhances T-cell responses to influenza vaccine in older adults H Behzad, ALW Huckriede, L Haynes, B Gentleman, K Coyle, JC Wilschut, ... Journal of Infectious Diseases 205 (3), 466-473, 2012 | 139 | 2012 |
| Mast cell and eosinophil activation are associated with COVID-19 and TLR-mediated viral inflammation: implications for an anti-Siglec-8 antibody S Gebremeskel, J Schanin, KM Coyle, M Butuci, T Luu, EC Brock, A Xu, ... Frontiers in immunology 12, 650331, 2021 | 114 | 2021 |
| Hide-and-seek: the interplay between cancer stem cells and the immune system M Sultan, KM Coyle, D Vidovic, ML Thomas, S Gujar, P Marcato Carcinogenesis 38 (2), 107-118, 2017 | 107 | 2017 |
| Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model EG Mathenge, CA Dean, D Clements, A Vaghar-Kashani, S Photopoulos, ... Neoplasia 16 (11), 950-960, 2014 | 107 | 2014 |
| Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3 ML Thomas, R De Antueno, KM Coyle, M Sultan, BM Cruickshank, ... Molecular oncology 10 (9), 1485-1496, 2016 | 104 | 2016 |
| ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells D Vidovic, TT Huynh, P Konda, C Dean, BM Cruickshank, M Sultan, ... Cell Death & Differentiation 27 (1), 363-378, 2020 | 96 | 2020 |
| Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma CK Rushton, SE Arthur, M Alcaide, M Cheung, A Jiang, KM Coyle, ... Blood advances 4 (13), 2886-2898, 2020 | 87 | 2020 |
| Genetic mutations and epigenetic modifications: driving cancer and informing precision medicine KM Coyle, JE Boudreau, P Marcato BioMed research international 2017 (1), 9620870, 2017 | 66 | 2017 |
| Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing P Pararajalingam, KM Coyle, SE Arthur, N Thomas, M Alcaide, ... Blood, The Journal of the American Society of Hematology 136 (5), 572-584, 2020 | 63 | 2020 |
| Epigenetic Silencing of TAP1 in Aldefluor+ Breast Cancer Stem Cells Contributes to Their Enhanced Immune Evasion M Sultan, D Vidovic, AS Paine, TT Huynh, KM Coyle, ML Thomas, ... Stem Cells 36 (5), 641-654, 2018 | 56 | 2018 |
| Chemoresistance in cancer stem cells and strategies to overcome resistance ML Thomas, KM Coyle, M Sultan, A Vaghar-Kashani, P Marcato Chemotherapy 3 (125), 2, 2014 | 46 | 2014 |
| Newly recruited CD11b+, GR-1+, Ly6Chigh myeloid cells augment tumor-associated immunosuppression immediately following the therapeutic administration of oncolytic reovirus DR Clements, AM Sterea, Y Kim, E Helson, CA Dean, A Nunokawa, ... The Journal of Immunology 194 (9), 4397-4412, 2015 | 39 | 2015 |
| Breast cancer subtype dictates DNA methylation and ALDH1A3-mediated expression of tumor suppressor RARRES1 KM Coyle, JP Murphy, D Vidovic, A Vaghar-Kashani, CA Dean, M Sultan, ... Oncotarget 7 (28), 44096, 2016 | 38 | 2016 |
| Phthalate esters affect maturation and function of primate testis tissue ectopically grafted in mice JR Rodriguez-Sosa, A Bondareva, L Tang, GF Avelar, KM Coyle, ... Molecular and cellular endocrinology 398 (1-2), 89-100, 2014 | 36 | 2014 |
| Retinoid signaling in cancer and its promise for therapy KM Coyle, M Sultan, ML Thomas, A Vaghar-Kashani, P Marcato J Carcinog Mutagen S 7, 16-18, 2013 | 35 | 2013 |
| Profiling of the transcriptional response to all-trans retinoic acid in breast cancer cells reveals RARE-independent mechanisms of gene expression KM Coyle, S Maxwell, ML Thomas, P Marcato Scientific Reports 7 (1), 16684, 2017 | 31 | 2017 |
| Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patterns K Dreval, LK Hilton, M Cruz, H Shaalan, S Ben-Neriah, M Boyle, ... Blood 142 (6), 561-573, 2023 | 30 | 2023 |
| Decitabine response in breast cancer requires efficient drug processing and is not limited by multidrug resistance ML Dahn, BM Cruickshank, AJ Jackson, C Dean, RW Holloway, SR Hall, ... Molecular cancer therapeutics 19 (5), 1110-1122, 2020 | 25 | 2020 |
| DNA methylation predicts the response of triple-negative breast cancers to all-trans retinoic acid KM Coyle, CA Dean, ML Thomas, D Vidovic, CA Giacomantonio, L Helyer, ... Cancers 10 (11), 397, 2018 | 25 | 2018 |
